Jacobio Pharmaceuticals Group Co (STU:77V) Net Change in Cash : €-54.13 Mil (TTM As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Jacobio Pharmaceuticals Group Co's Net Change in Cash for the six months ended in Jun. 2024 was €-13.75 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was €-54.13 Mil.

Jacobio Pharmaceuticals Group Co Net Change in Cash Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Net Change in Cash Chart

Jacobio Pharmaceuticals Group Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

140.29

13.45

-122.25

-19.94

Jacobio Pharmaceuticals Group Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Change in Cash	Get a 7-Day Free Trial								-113.13	20.52	-40.39	-13.75	-

Jacobio Pharmaceuticals Group Co Net Change in Cash Calculation

Jacobio Pharmaceuticals Group Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-46.773	+	-6.165	+	31.629	+	1.374
	=	-19.94

Jacobio Pharmaceuticals Group Co's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -23.104 + 5.596 + 3.299 + 0.464

= -13.75

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-54.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobio Pharmaceuticals Group Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (STU:77V) » Definitions » Net Change in Cash

Comparable Companies

HKSE:02509 HKSE:02137 HKSE:02487 HKSE:02566 HKSE:01875 HKSE:06996 HKSE:02496 HKSE:02181 HKSE:03681 HKSE:06978 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270

Traded in Other Exchanges

01167:Hong Kong

Address

No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN

Website

https://www.jacobiopharma.com

Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Jacobio Pharmaceuticals Group Co Headlines

No Headlines